Oxbow Advisors’s Tenet Healthcare THC Stock Holding History

Oxbow Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-69,300	Closed	-$1.34M	–	248
2017 Q2	$1.34M	Sell	69,300 -80	-0.1%	-$1.4K	0.24%	110
2017 Q1	$1.23M	Buy	+69,380	New	+$1.29M	0.2%	118

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WAM

Warlander Asset Management New York $111M AUM 8.26% 1-Year Est. Return

Oxbow Advisors's THC Position: Q3 2017 in Review

Oxbow Advisors sold out of Tenet Healthcare (THC) in Q3 2017, closing a stake of 69,300 shares — an estimated $1.34M sold.

Oxbow Advisors first reported a position in THC in Q1 2017 and held it in 2 quarters. The position peaked at $1.34M in Q2 2017. 243 funds tracked by Wall St. Rank hold THC as of Q3 2017.

Oxbow Advisors reported no remaining Tenet Healthcare position as of Q3 2017 after selling out during the quarter.
Oxbow Advisors sold 69,300 Tenet Healthcare shares in Q3 2017, an estimated $1.34M.
Oxbow Advisors first reported a position in Tenet Healthcare in Q1 2017 and held it in 2 quarters.
Oxbow Advisors's Tenet Healthcare position peaked at $1.34M in Q2 2017.
243 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2017.

Based on Oxbow Advisors's 13F filing for Q3 2017, filed 23 Oct 2017.